argenx SE Investor Day Presentation Deck slide image

argenx SE Investor Day Presentation Deck

Efgartigimod Keeps FcRn in its Recycling Path FcRn over time 0 min No treatment argenx 0 min Efgartigimod 0 min Control anti-FcRn mAb Normalized Volume (%) 150- 100 50- Normalized Sum Volume (FcRn) -0 -09 120- 180- 240- 300- 360- 420- -087 540- -009 -099 Time (Min) ********* 720- 780- 840- No treatment → Efgartigimod → Control anti-FcRn mAb -006 096 19
View entire presentation